NEW YORK (GenomeWeb) – Startup company Viome announced today that it has raised $15 million in Series A funding to support the launch of its at-home human microbiome testing kit.

The company is currently functioning in beta mode, with thousands of customers using the product.

Viome's first round of venture capital financing was led by Khosla Ventures, with participation from Bold Capital partners. Khosla Ventures, led by managing partner Vinod Khoshla, will receive one seat on Viome's board. The company also noted it has now raised a total of $21 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.